Prihlásiť sa Zaregistrujte sa zadarmo

Návratnosť imania spoločnosti Novabay Pharmaceuticals Inc

Aká je hodnota metriky Návratnosť imania spoločnosti Novabay Pharmaceuticals Inc?

Hodnota metriky Návratnosť imania spoločnosti Novabay Pharmaceuticals Inc je -431.13%

Aká je definícia metriky Návratnosť imania?



Návratnosť imania (Return on equity - ROE) je rentabilita vlastného imania. Vypočíta sa vydelením čistého príjmu za fiškálny rok vlastným imaním.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Návratnosť imania spoločností v sektore Health Care sektor na NYSEMKT v porovnaní so spoločnosťou Novabay Pharmaceuticals Inc

Čomu sa venuje spoločnosť Novabay Pharmaceuticals Inc?

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Firmy s metrikou návratnosť imania podobnou spoločnosti Novabay Pharmaceuticals Inc